期刊文献+

SELDI技术分析肾母细胞瘤体外和体内分泌蛋白质的表达 被引量:1

Analysis of secretory protein expression on Wilms' tumor in vitro and in vivo by SELDI technique
原文传递
导出
摘要 目的运用表面增强激光解析电离飞行时间质谱(SELDI-TOF-MS)技术分析肾母细胞瘤细胞株G401细胞培养液与正常胚肾细胞株CCC-HKE-1细胞培养液的差异蛋白质,分析G401利用血清中的蛋白质,并比较G401培养液与患儿血清存在的相似蛋白质。方法培养含10%胎牛血清及无血清的G401细胞和含10%胎牛血清的胚肾细胞株CCC-HEK-1细胞,收集以上三种培养液及G401裂解液,收集肾母细胞瘤患儿术前血清。将以上样本应用于WCX2(弱阳离子交换)芯片,用SELDI-TOF-MS技术检测、阅读和分析各组间差异及相似蛋白质。结果G401和CCC-HEK-1培养液间存在显著的蛋白质差异表达;G401分泌的蛋白质质荷比有:3996、4084、4144、4215、4232、5980、6069、6094、6855、8553Da;G401利用血清中的蛋白质质荷比有:3830、3917、4144、4460、4795、4932、5688、5981、6023、6050、6075、6094、6188、6203、6857、7064、7308、7964Da;质荷比为4082、4143Da的蛋白质在肿瘤细胞培养液和患儿血清中都检测到。结论SELDI-TOF-MS技术应用于体外培养的肾母细胞瘤细胞和患儿血清方法简便、敏感性高、重复性好;从而为从蛋白质水平研究肾母细胞瘤的发病机制和治疗靶位的寻找奠定基础。 Objective To analyze the differentially expressed protein between cell culture medium of Wilms' tumor cell line G401 and normal embryonic kidney cell line CCC-HEK-1, and compare the similar protein between cell culture medium of G401 and patients' serum by SELDI-TOF-MS technique. Methods G401 and CCC-HEK-1 with 10% FCS, G401 without FCS and the lysate of G401 were collected. The serum of Wilms' tumor patients before operation was gathered in WCX2 proteinchip. The difference and similar proteins were detected and analyzed by SELDI-TOF-MS technique. Results Significantly different proteins were detected between cell culture medium G401 and CCC- HEK-1. G401 secretory proteins with molecular weight (MW, Da) were 3996, 4084, 4144, 4215, 4232, 5980, 6069, 6094, 6855, and 8553. G401 consumed serum proteins with MW (Da) were 3830, 3917, 4144, 4460, 4795, 4932, 5688, 5981, 6023, 6050, 6075, 6094, 6188, 6203, 6857, 7064, 7308 and 7964. Protein with MW (Da) of 4082 and 4143 were expressed in both G401 cell culture medium and the serum of Wilms' tumor cases. Conclusions The advantages of SELDI-TOF-MS technique are simple, high sensibility and repeatable in vitro and in vivo. It's useful to investigate the pathogenesis and therapeutic targets of Wilms' tumors.
出处 《中华小儿外科杂志》 CSCD 北大核心 2009年第3期163-167,共5页 Chinese Journal of Pediatric Surgery
基金 国家自然科学基金资助项目(30772273) 河南省卫生厅科技攻关计划项目(200802004)
关键词 肾母细胞瘤 蛋白质组学 SELDI技术 临床分析 Wilms' tumor Proteomics
  • 相关文献

参考文献5

二级参考文献32

共引文献24

同被引文献16

  • 1张谦,单岩,陈清江.血管内皮生长因子在预测肾母细胞瘤转移中的作用[J].中华儿科杂志,2005,43(3):213-213. 被引量:4
  • 2黄俊辉,李洋,刘亮,杨怀才,海健,唐利立,胡铁辉.VEGF-C介导的乳腺癌肿瘤淋巴管生成及定位[J].中南大学学报(医学版),2006,31(1):36-39. 被引量:10
  • 3王家祥,陈新让,张蛟,刘秋亮,李苏宁,余捷凯,郑树.肾母细胞瘤血清蛋白质标记物检测与分期模型构建研究[J].中华小儿外科杂志,2007,28(2):90-94. 被引量:11
  • 4Qing Y,Shuo W,Zhihua W,et al. The in vitro antitumor effect and in vivo tumor-specificity distribution of human mouse chimeric antibody against transferrin receptor . Cancer Immunol Immunother , 2006,55 (9) : 1111-1121.
  • 5Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth facter specific for vascular endothelial cells. Biochem Biophys Res Commun, 1989,161 (2):851-858.
  • 6de Castro Junior G, Puglisi F, de Azambuja E, et al. Angiogene sis and cancer: a cross-talk between basic science and clinical trails. Crit Rev Oncol Hematol,2006,59(1 ) :40-50.
  • 7Chen A, Cuevas I, Kenny PA, et al. Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity. Cancer Res, 2009,69 (16):6721-6729.
  • 8Wang H,Bloom O,Zhang M,et al. HMGB1 as a late mediator of endotoxin lethality in mice. Science, 1999,285 (5425):248-251.
  • 9Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature,2002, 418(6894) : 191-195.
  • 10Thorburn J, Frankel AE, ThorburnA. Regulation of HMGB1 release by autophagy. Autophagy, 2009, 5 (2):247-249.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部